Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Kidney Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00397345
What this trial is testing

TroVax Renal Immunotherapy Survival Trial

Who this might be right for
Clear Cell Renal Carcinoma
Oxford BioMedica 733
Testing effectiveness (Phase 2)Looking for participantsNCT07571551
What this trial is testing

Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell RCC
Jinling Hospital, China 75
Testing effectiveness (Phase 2)Looking for participantsNCT06940518
What this trial is testing

Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
IvonescimabClear Cell Renal Carcinoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Testing effectiveness (Phase 2)UnknownNCT01069770
What this trial is testing

Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastasis
Korean Urological Oncology Society 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05808608
What this trial is testing

AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaFirst-line TreatmentNon Clear Cell Renal Cell Carcinoma+1 more
Hao Zeng 37
Testing effectiveness (Phase 2)Looking for participantsNCT06211790
What this trial is testing

Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma

Who this might be right for
Kidney CancerRenal Cell CarcinomaRenal Clear Cell Carcinoma
Fudan University 66
Testing effectiveness (Phase 2)Study completedNCT00866320
What this trial is testing

Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center 49
Early research (Phase 1)Study completedNCT04518046
What this trial is testing

Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies

Who this might be right for
Clear-Cell Renal Cell Carcinoma
Mirati Therapeutics Inc. 22
Testing effectiveness (Phase 2)Study completedNCT01354431
What this trial is testing

BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 168
Not applicableWithdrawnNCT01977586
What this trial is testing

Functional Imaging in the Assessment of mRCC Response to Sunitinib

Who this might be right for
Metastatic Renal Cell Carcinoma
Imperial College Healthcare NHS Trust
Early research (Phase 1)Study completedNCT02315066
What this trial is testing

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

Who this might be right for
Neoplasms
Pfizer 174
Testing effectiveness (Phase 2)Study completedNCT02700568
What this trial is testing

Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors

Who this might be right for
Carcinoma, Renal CellClear Cell Renal Cell Carcinoma
Kidney Cancer Research Bureau 21
Not applicableWithdrawnNCT00499291
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Who this might be right for
Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Ended earlyNCT02595918
What this trial is testing

Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7+3 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012371
What this trial is testing

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Ended earlyNCT01582009
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more
Roswell Park Cancer Institute 26
Early research (Phase 1)Study completedNCT00258687
What this trial is testing

Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma

Who this might be right for
Sarcoma, Clear CellSarcoma, Alveolar Soft PartRenal Cell Carcinoma+1 more
Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT01499121
What this trial is testing

Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule

Who this might be right for
Clear Cell, Metastatic Renal Cell Carcinoma
Sunnybrook Health Sciences Centre 117
Early research (Phase 1)Looking for participantsNCT07062549
What this trial is testing

Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Next Page